The possible perils of targeted therapy

Leukemia. 2016 Jul;30(7):1619-21. doi: 10.1038/leu.2016.18. Epub 2016 Feb 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Bispecific / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Female
  • Histone-Lysine N-Methyltransferase / genetics
  • Humans
  • Leukemia, Monocytic, Acute / etiology*
  • Leukemia, Monocytic, Acute / genetics
  • Molecular Targeted Therapy / adverse effects*
  • Myeloid-Lymphoid Leukemia Protein / genetics
  • Neoplasms, Second Primary / genetics*
  • Neoplasms, Second Primary / pathology
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Young Adult

Substances

  • Antibodies, Bispecific
  • Antineoplastic Agents, Immunological
  • KMT2A protein, human
  • Myeloid-Lymphoid Leukemia Protein
  • blinatumomab
  • Histone-Lysine N-Methyltransferase